Works well, helps curve appetite
Native IGF-1 binds IGFBP-3, the dominant carrier protein in circulation, with a dissociation constant in the low nanomolar range (Kd approximately 0.1 to 1 nM in most published binding assays)
In patients without oxidative stress markers, excessive supplementation may impair immune functioning
This compounded preparation: Has not been approved by the FDA Has not undergone FDA review for safety, effectiveness, or quality Is prepared specifically for you based on your prescriber's order Individual outcomes may vary Disclaimer: Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the U.S
In laboratory research, AOD 9604 is used to explore pathways involved in fat breakdown (lipolysis), fat storage (lipogenesis), and energy use, without the broader endocrine activity associated with full-length growth hormone